recent articles

Ibex: Our AI Algorithm to Aid Pathologists with Accurate and Reproducible HER2 and HER2-low Assessment in Breast Cancer Diagnosis TEL AVIV, Israel, Jan. 24, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer...

Rudy Hovelinck joins Pathomation as Chief Operational Officer (COO) on February 21, 2022. ANTWERP, BELGIUM (PRWEB) FEBRUARY 18, 2022 Pathomation today announced that Rudy Hovelinck will fill in the new position of Chief Operational Officer...

Big news this morning with acquisition of Definiens by MedImmune, strengthening MedImmune's focus on the discovery of novel predictive biomarkers in immune-oncology. Good news for patients and their providers. Tuesday, 4 November 2014 -...

OR

platinum partners

gold partners

Silver Partners

Media Partners